MODERNA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.41 CHF | +1.01% |
|
-39.82% | -47.70% |
| Jul. 15 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
| Jul. 12 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 41.47B | ||||||
| 42.45B | ||||||
| 31.6B | - | |||||
| 28.63B | ||||||
| 28.03B |
